Next Steps in Content Usage
21st October 2015

Read

UK Legal Research 2015 (Purchase Drivers and Philosophy)
21st October 2015

In the third part of FreePint's research into purchasing trends and preferences in the UK legal market, FreePint's director of research, Robin Neidorf, explains how the survey explored purchasing philosophies, relationships with vendors, out-of-cycle purchases, and the blurring between content and technology.

Read

Product Review of Factiva (Competitors, Development & Pricing)
21st October 2015

Andrew Grave completes his product review of premium global news database Factiva, looking at standout developments over the past two years, licensing plans, pricing, and competitors which include Nexis, Westlaw UK and FirstRain.

Note: Full review (PDF) at /go/sub/report/2558

Read

UK Legal Research 2015 (Use of Core Products)
20th October 2015

In the second part of FreePint's research into purchasing trends and preferences in the UK legal market, we look at how respondents rate LexisLibrary, Lexis PSL, Westlaw UK and Practical Law, according to their overall perception of content quality, content coverage, technology and ease of use, and ROI.

Read

Product Review of Factiva (Technology - Outputs & Alerts; Administration & Help)
20th October 2015

Reviewer Andrew Grave continues his in-depth review of Factiva, Dow Jones' premium news aggregation service. In part 4 he examines the way in which search results can be exported, analysed, converted into alerts and displayed on tailored pages. He also looks at support and training. New developments in outputs, enhancements to other features and improvements to functionality since Factiva was last reviewed in FreePint are also included.

Note: Full review (PDF) at /go/sub/report/2558

Read

Q&A with ProQuest and Pi2 - Literature Monitoring in Drug Safety
20th October 2015

We interviewed ProQuest and Pi2 management to find out more about the value of Pi2 to ProQuest's corporate pharmaceutical customers, how it helps drug safety departments to cope with increasing workloads and what makes for most effective literature monitoring in drug safety.

Read

UK Legal Research 2015 (Introduction, History, Methodology and Respondent Pool)
20th October 2015

FreePint has conducted research into purchasing trends and preferences in the UK legal market since 2010. Director of research, Robin Neidorf, introduces this year's findings, looking at whether content budgets are increasing, diminishing or remaining stable; influencers over specification and purchase; and which stakeholders are involved with overall content budget approval.

Read

Q&A with Eduserv - Authentication in the Information Industry
19th October 2015

The corporate pharma field is research-intensive with literature searching a key component of the work. We interview Eduserv and find out more about their OpenAthens access management product, specfic authentication and access challenges facing corporate libraries, and how Eduserv aims to bring organisations and publishers closer to seamless user access.

Read

Product Review of Factiva (Technology - Search & User Interface)
19th October 2015

In the third part of his product review, Andrew Grave takes a close look at news aggregator Factiva's functionality. His review includes the two search tools and the homepages. Query Genius, introduced last year, the newsletter function, and the various news pages which can be tailored to display content according to each user's needs are assessed. In addition, he covers new features such as this year's additions to Factiva Intelligent Indexing.

Note: Full review (PDF) at /go/sub/report/2558

Read

Reflecting on the FreePint Topic Series "All About Usage"
16th October 2015

As the FreePint Topic Series "All About Usage - From Content Sharing to Data Mining" reaches its conclusion, co-producer Andrew Lucas looks back over the series and highlights some of the key articles and events on subjects from authentication to content rights and responsibilities, original research and resource management. He also considers some of the key findings and next steps from the series.

Read